Mild and Efficient Synthesis of Fmoc-Protected Amino Azides from Fmoc-Protected Amino Alcohols

Abstract

Fmoc-protected amino azides - key intermediates for monomers of oligomeric urea and guanidine - can be efficiently prepared from the corresponding amino alcohol through iodination followed by substitution with sodium azide. This synthetic route avoids the preparation, storage, and handling of the highly toxic azidic acid that is used in an alternative method.

amino azides - amino alcohols - iodine

References and Notes

1 Soth MJ. Nowick JS. Curr. Opin. Chem. Biol.  1997,  1:  120 

2 Schneider SE. Anslyn EV. Molecular Recognition and Solid Phase Organic Synthesis: Synthesis of Unnatural Oligomers, Techniques for Monitoring Reactions, and the Analysis of Combinatorial Libraries, In Advances in Supramolecular Chemistry   Vol. 5:  Gokel GW. JAI Press; Stamford CT: 1999.  p.55-120  

3 Kirshenbaum K. Zuckermann RN. Dill KA. Curr. Opin. Struct. Biol.  1999,  9:  530 

4 Cheng RP. Gellman SH. DeGrado WF. Chem. Rev.  2001,  101:  3219 

5 Hill DJ. Mio MJ. Prince RB. Hughes TS. Moore JS. Chem. Rev.  2001,  101:  3893 

6 Oh K. Jeong KS. Moore JS. Nature (London)  2001,  414:  889 

7 Burgess K. Linthicum DS. Shin HW. Angew. Chem., Int. Ed. Engl.  1995,  34:  907 

8 Kim JM. Bi YZ. Paikoff SJ. Schultz PG. Tetrahedron Lett.  1996,  37:  5305 

9 Burgess K. Ibarzo J. Linthicum DS. Russell DH. Shin H. Shitangkoon A. Totani R. Zhang AJ. J. Am. Chem. Soc.  1997,  119:  1556 

10 Boeijen A. van Ameijde J. Liskamp RMJ. J. Org. Chem.  2001,  66:  8454 

11 Guichard G. Semetey V. Rodriguez M. Briand J.-P. Tetrahedron Lett.  2000,  41:  1553 

12 Dempcy RO. Luo J. Bruice TC. Proc. Natl. Acad. Sci. U.S.A.  1996,  93:  4326 

13 Tanatani A. Kagechika H. Azumaya I. Fukutomi R. Ito Y. Yamaguchi K. Shudo K. Tetrahedron Lett.  1997,  38:  4425 

14 Schneider SE. Bishop PA. Salazar MA. Bishop OA. Anslyn EV. Tetrahedron  1998,  54:  15063 

15 Tanatani A. Yamaguchi K. Azumaya I. Fukutomi R. Shudo K. Kagechika H. J. Am. Chem. Soc.  1998,  120:  6433 

16 Linkletter BA. Bruice TC. Bioorg. Med. Chem. Lett.  1998,  8:  1285 

17 Linkletter BA. Szabo IE. Bruice TC. J. Am. Chem. Soc.  1999,  121:  3888 

18 Linkletter BA. Bruice TC. Bioorg. Med. Chem.  2000,  8:  1893 

19 Zhang Z. Carter T. Fan E. Tetrahedron Lett.  2003,  44:  3063 

20 Zhang Z. Fan E. J. Org. Chem.  2005,  70:  8801 

21 Horwell DC. Hughes J. Hunter JC. Pritchard MC. Richardson RS. Roberts E. Woodruff GN. J. Med. Chem.  1991,  34:  404 

22 Tornoe CW. Christensen C. Meldal M. J. Org. Chem.  2002,  67:  3057 

23 Wolff H. Schmidt Reaction, In Organic Reactions   Vol. 3:  Adams R. Bacjmann WE. Fieser LF. Johnson JR. Snyder HR. John Wiley and Sons; New York: 1947.  p.307-336  

24 Garegg PJ. Samuelsson B. J. Chem. Soc., Chem. Commun.  1979,  978 

25 Benito JM. Christensen CA. Meldal M. Org. Lett.  2005,  7:  581 

26 Olsen CA. Witt M. Jaroszewski JW. Franzyk H. Org. Lett.  2004,  6:  1935 

27 Rodriguez M. Llinares M. Doulut S. Heitz A. Martinez J. Tetrahedron Lett.  1991,  32:  923 

28

All compounds gave satisfactory analytical data. Described below are a representative procedure and spectral data for Fmoc-protected glutamate azide 2h. Fmoc-protected glutamate alcohol 1h (50 mg, 0.12 mmol) in dry CH₂Cl₂ was added to a pre-mixed (5 min) solution of PPh₃ (94 mg, 0.36 mmol, 3 equiv), iodine (91 mg, 0.36 mmol, 3 equiv) and imidazole (41 mg, 0.6 mmol, 5 equiv) in 1.2 mL dry CH₂Cl₂. The reaction mixture was stirred at r.t. for 1.5 h. After completion of the reaction the solvent was evaporated at reduced pressure and the corresponding iodide was purified by silica gel column chromatography (10% EtOAc in hexane). The iodide was then dissolved in 0.5 mL DMF, mixed with NaN₃ (39 mg, 0.6 mmol, 5 equiv with respect to alcohol 1h) and stirred at r.t. for 3.5 h. After solvent removal and silica gel column chromatography (10% EtOAc in hexane), azide 2h was obtained as a white solid in high yield. Yield 50 mg (94% overall from alcohol 1h); mp 65-66 °C. ¹H NMR (CDCl₃): δ = 1.47 (s, 9 H), 1.82-1.86 (m, 2 H), 2.29-2.36 (m, 2 H), 3.42-3.48 (m, 2 H), 3.75-3.87 (br m, 1 H), 4.23 (t, 1 H, J = 6.9 Hz), 4.38-4.50 (m, 2 H), 5.03 (d, 1 H, J = 7.7 Hz), 7.31-7.45 (m, 4 H), 7.61 (d, 2 H, J = 7.2 Hz), 7.79 (d, 2 H, J = 7.2 Hz). ESI-MS: m/z = 437.0 [M + H]⁺.
Additional list of ¹H NMR of new compounds:
Compound 2g: ¹H NMR (CDCl₃): δ = 1.76-1.83 (m, 2 H), 2.29-2.31 (m, 2 H), 3.31-3.37 (m, 2 H), 3.72 (br m, 1 H), 4.20 (t, 1 H, J = 6.5 Hz), 4.37-4.50 (m, 2 H), 5.01 (d, 1 H, J = 7.9 Hz), 6.75 (s, 1 H), 7.18-7.29 (m, 17 H), 7.35-7.41 (m, 2 H), 7.57 (d, 2 H, J = 7.4 Hz), 7.74 (d, 2 H, J = 7.4 Hz).
Compound 2i: ¹H NMR (CDCl₃): δ = 1.42 (s, 6 H), 1.41-1.58 (m, 4 H), 2.06 (s, 3 H), 2.49 (s, 3 H), 2.56 (s, 3 H), 2.90 (s, 2 H), 3.16-3.31 (m, 4 H), 3.72 (br m, 1 H), 4.14 (t, 1 H, J = 6.5 Hz), 4.32-4.41 (m, 2 H), 5.30 (d, 1 H, J = 8.4 Hz), 6.34 (br s, 2 H), 7.24-7.27 (m, 2 H), 7.34-7.38 (m, 2 H), 7.54-7.55 (m, 2 H), 7.73 (d, 2 H, J = 7.4 Hz).
Compound 2j: ¹H NMR (CDCl₃): δ = 1.65 (s, 9 H), 2.93-2.99 (m, 2 H), 3.45-3.49 (m, 2 H), 4.17-4.22 (m, 2 H), 4.41-4.43 (m, 2 H) 4.98 (d, 1 H, J = 7.8 Hz), 7.27-7.41 (m, 6 H), 7.46-7.63 (m, 4 Hz), 7.76 (d, 2 H, J = 7.4 Hz), 8.14 (br s, 1 H).